TECX (Tectonic Therapeutic, Inc.) Stock Financials & Earnings | Market Cap Arena

TECX (Tectonic Therapeutic, Inc.) Stock Financials & Earnings | Market Cap Arena

TECXTectonic Therapeutic, Inc.

Mkt Cap$635M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$74M

EPS (TTM)-$4.05

Free Cash Flow (TTM)-$60M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	-$920K	-$25M
Q2 23	$0	$0	-$11M
Q3 23	$0	$0	-$10M
Q4 23	$0	$0	-$9M
Q1 24	$0	$0	-$13M
Q2 24	$0	$0	-$11M
Q3 24	$0	$0	-$20M
Q4 24	$0	$0	-$14M
Q1 25	$0	$0	-$18M
Q2 25	$0	$0	-$22M
Q3 25	$0	$0	-$22M
Q4 25	$0	$0	-$22M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$20M	-$20M
Q2 23	-$259K	-$473K
Q3 23	-$8M	-$8M
Q4 23	-$12M	-$12M
Q1 24	-$9M	-$9M
Q2 24	-$13M	-$13M
Q3 24	-$20M	-$20M
Q4 24	-$17M	-$17M
Q1 25	-$13M	-$13M
Q2 25	-$15M	-$15M
Q3 25	-$18M	-$18M
Q4 25	-$14M	-$14M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$8K
Q2 23	$214K
Q3 23	$7K
Q4 23	$50K
Q1 24	$4K
Q2 24	$4K
Q3 24	$153K
Q4 24	$3K
Q1 25	$27K
Q2 25	$27K
Q3 25	$181K
Q4 25	$27K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	-14.3%
Q2 23	—	-61.7%
Q3 23	—	-56.0%
Q4 23	—	-9.4%
Q1 24	—	-48.6%
Q2 24	—	+7.4%
Q3 24	—	+94.2%
Q4 24	—	+49.3%
Q1 25	—	+41.1%
Q2 25	—	+95.5%
Q3 25	—	+11.5%
Q4 25	—	+53.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$0	—
Q2 23	$0	—
Q3 23	$275K	—
Q4 23	$294K	—
Q1 24	$321K	—
Q2 24	$403K	—
Q3 24	$2M	—
Q4 24	$1M	—
Q1 25	$2M	—
Q2 25	$5M	—
Q3 25	$3M	—
Q4 25	$5M	—

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$17M	$2M	$6M
Q2 23	$9M	$2M	—
Q3 23	$8M	$2M	—
Q4 23	$7M	$2M	—
Q1 24	$11M	$2M	—
Q2 24	$7M	$4M	—
Q3 24	$14M	$5M	—
Q4 24	$9M	$5M	—
Q1 25	$13M	$5M	—
Q2 25	$17M	$5M	—
Q3 25	$17M	$5M	—
Q4 25	$16M	$5M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$72M	$0	$72M
Q2 23	$125M	$0	$125M
Q3 23	$6M	$0	$6M
Q4 23	$29M	$0	$29M
Q1 24	$91M	$0	$91M
Q2 24	$185M	$0	$185M
Q3 24	$159M	$0	$159M
Q4 24	$141M	$0	$141M
Q1 25	$306M	$0	$306M
Q2 25	$287M	$0	$287M
Q3 25	$268M	$0	$268M
Q4 25	$254M	$0	$254M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	4M	+0.6%
Q2 23	4M	+0.6%
Q3 23	4M	+0.6%
Q4 23	4M	+0.3%
Q1 24	4M	+0.3%
Q2 24	15M	+294.7%
Q3 24	15M	+0.1%
Q4 24	15M	+0.3%
Q1 25	17M	+16.0%
Q2 25	19M	+8.9%
Q3 25	19M	+0.2%
Q4 25	18M	-2.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 16	—	—
FY 17	—	—
FY 18	$0	49
FY 19	$0	85
FY 20	$0	121
FY 21	$0	122
FY 22	$0	78
FY 23	$0	13
FY 24	$0	51
FY 25	$0	75K